Savant Capital LLC Decreases Stock Position in Colgate-Palmolive Company $CL

Savant Capital LLC trimmed its position in shares of Colgate-Palmolive Company (NYSE:CL) by 23.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,041 shares of the company’s stock after selling 11,294 shares during the quarter. Savant Capital LLC’s holdings in Colgate-Palmolive were worth $3,276,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Grimes & Company Inc. grew its holdings in shares of Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after buying an additional 118 shares in the last quarter. RFG Advisory LLC boosted its position in Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after acquiring an additional 123 shares during the last quarter. Redhawk Wealth Advisors Inc. grew its stake in Colgate-Palmolive by 2.4% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after acquiring an additional 129 shares in the last quarter. Westside Investment Management Inc. raised its holdings in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the last quarter. Finally, MONECO Advisors LLC raised its holdings in Colgate-Palmolive by 2.2% in the 1st quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock valued at $567,000 after acquiring an additional 133 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CL. The Goldman Sachs Group lowered their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a report on Monday, November 3rd. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Raymond James Financial lowered their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $78.76 on Monday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market cap of $63.48 billion, a P/E ratio of 22.12, a P/E/G ratio of 4.44 and a beta of 0.35. The firm’s 50 day moving average price is $79.73 and its 200-day moving average price is $85.64. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the previous year, the company earned $0.91 earnings per share. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.